Celgene Corporation
Registered Principal Details
Business Or Interest:
Biopharmaceutical company.
Lobbying Interests:
Health care access to pharmaceuticals, biotechnology issues, and cancer drug repository programs.
CEO Name:
Bob Hugin
Vice President
Biopharmaceutical company.
Lobbying Interests:
Health care access to pharmaceuticals, biotechnology issues, and cancer drug repository programs.
CEO Name:
Bob Hugin
Vice President
Contact
AMF
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 151
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.
Bill Text and History
5/26/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
Ensure patient access to FDA-approved oral chemotherapy within health plans that currently cover chemotherapy.
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.
Bill Text and History
For
Notification Date5/26/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
Ensure patient access to FDA-approved oral chemotherapy within health plans that currently cover chemotherapy.
Senate Bill 101
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.
Bill Text and History
5/26/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
Ensure patient access to FDA-approved oral chemotherapy within health plans that currently cover chemotherapy.
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.
Bill Text and History
For
Notification Date5/26/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
Ensure patient access to FDA-approved oral chemotherapy within health plans that currently cover chemotherapy.
Topics Not Yet Assigned A Bill Or Rule Number
Resolution recognizing the importance of placenta-cord blood banking and research utilizing placenta-cord blood stem cells; Calling for increased public awareness about the option of banking placenta and cord blood.
Development, drafting or introduction of a proposal relating to
Resolution recognizing the importance of placenta-cord blood banking and research utilizing placenta-cord blood stem cells; Calling for increased public awareness about the option of banking placenta and cord blood.
Resolution recognizing the importance of placenta-cord blood banking and research utilizing placenta-cord blood stem cells; Calling for increased public awareness about the option of banking placenta and cord blood.
Action Intended To Affect
Legislative Matter
Notification Date
3/27/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
3/27/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Bills to revamp Wisconsin's cancer and chronic disease drug repository program.
Bills to revamp Wisconsin's cancer and chronic disease drug repository program.
Action Intended To Affect
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Seeking agency action within the Department of Health Services to ensure that FDA-mandated restricted distribution drugs are not accepted and redispensed in violation of FDA risk management programs.
Development, drafting or introduction of a proposal relating to
Seeking agency action within the Department of Health Services to ensure that FDA-mandated restricted distribution drugs are not accepted and redispensed in violation of FDA risk management programs.
Seeking agency action within the Department of Health Services to ensure that FDA-mandated restricted distribution drugs are not accepted and redispensed in violation of FDA risk management programs.
Action Intended To Affect
Rule (by a state agency)
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Rule (by a state agency)
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
The lack of necessity for new laws restricting the access of pharmaceutical sales representatives and promoting the role these professionals have working with physicians to ensure patient access to needed drugs.
Development, drafting or introduction of a proposal relating to
The lack of necessity for new laws restricting the access of pharmaceutical sales representatives and promoting the role these professionals have working with physicians to ensure patient access to needed drugs.
The lack of necessity for new laws restricting the access of pharmaceutical sales representatives and promoting the role these professionals have working with physicians to ensure patient access to needed drugs.
Action Intended To Affect
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Draft resolution regarding placenta blood/cord blood banking and research.
Draft resolution regarding placenta blood/cord blood banking and research.
Action Intended To Affect
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Oral Oncology Fairness: legislation requiring coverage of oral cancer therapies to be no less favorable than injectable/IV therapies.
Development, drafting or introduction of a proposal relating to
Oral Oncology Fairness: legislation requiring coverage of oral cancer therapies to be no less favorable than injectable/IV therapies.
Oral Oncology Fairness: legislation requiring coverage of oral cancer therapies to be no less favorable than injectable/IV therapies.
Action Intended To Affect
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Potential Assembly Resolution regarding public awareness of cord blood/placenta blood banking and research.
Development, drafting or introduction of a proposal relating to
Potential Assembly Resolution regarding public awareness of cord blood/placenta blood banking and research.
Potential Assembly Resolution regarding public awareness of cord blood/placenta blood banking and research.
Action Intended To Affect
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Total Lobbying Effort
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2011 January - June $30,967.16 |
2011 July - December $29,479.03 |
2012 January - June $26,908.49 |
2012 July - December $25,943.50 |
Total $113,298.18 |
| Total Hours Communicating | 2011 January - June 101.50 |
2011 July - December 50.75 |
2012 January - June 28.50 |
2012 July - December 1.00 |
Total 181.75 |
| Total Hours Other | 2011 January - June 133.50 |
2011 July - December 111.75 |
2012 January - June 49.00 |
2012 July - December 63.50 |
Total 357.75 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June 50% |
2011 July - December 50% |
2012 January - June 50% |
2012 July - December 50% |
Total 50% |
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June 50% |
2011 July - December 50% |
2012 January - June 50% |
2012 July - December 50% |
Total 50% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
No topics found.
Minor Efforts
No minor efforts found.
Other Matters
No other matters found.